Integrin α3β1 has been shown to initiate FAK signalling and promote malignant proliferation and invasion in cancers such as breast cancer [37], ovarian cancer [22], head and neck cancer [23,24] and pancreatic cancer [18,25,38]. Here, PTK2 is linked to breast cancer.